Hyvalker Allan Correia do Amaral | Oncobiology Symposium | Galoá Proceedings

Federal University of Rio de Janeiro

Hyvalker Allan Correia do Amaral

Papers (3)

DEVELOPMENT OF A INTESTINAL MINI-ORGAN PLATFORM FOR TESTING FIRST-LINE PHARMACEUTICALS COMBINED WITH WNT/β-CATENIN PATHWAY INHIBITOR CHEMICAL COMPOUNDS
Julia França ¹
Hyvalker Allan Correia do Amaral ¹
Luiz Fernando Silva Oliveira ¹
José Garcia Abreu ¹
¹ Universidade Federal do Rio de Janeiro
Vol 3, 2022 -
155243

2. Cellular Biology

IC - Undergraduate Students
β-CATENIN DESTABILIZATION OVERCOMES 5-FU RESISTANCE AND SYNERGISTICALLY IMPAIRS COLORECTAL CANCER GROWTH
Luiz Fernando Silva Oliveira ¹
Julia França ¹
Hyvalker Allan Correia do Amaral ¹
Helena Lobo Borges ¹
José Garcia Abreu ¹
¹ Universidade Federal do Rio de Janeiro
Vol 3, 2022 -
155263

7. Cell Signaling

PD - PostDoctoral
INHIBITION OF THE WNT/β-CATENIN PATHWAY ENHANCE 5-FU EFFECTS IN MICE MODEL OF COLORECTAL CANCER
Hyvalker Allan Correia do Amaral ¹
Luiz Fernando Silva Oliveira ¹
José Garcia Abreu ¹
¹ Universidade Federal do Rio de Janeiro
Vol 3, 2022 -
155264

2. Cellular Biology

MS - Masters student

Co-authors (4)